Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Pilot Projects in Aging

Université Laval

$50,000.00

Study of the microRNA pathway in platelets of elderly dialysis and chronic kidney disease patients

FY 2008-09

Summary
A finely tuned regulatory control of gene expression is required in order to maintain homeostasis and to remain healthy. Recent studies unveiled the existence and biological significance of a gene regulatory mechanism based on tiny RNA species called microRNAs. Generated by the ribonuclease III Dicer, an enzyme that we discovered, microRNAs may regulate up to 90% of the genes, suggesting that every metabolic processes may be under microRNA control in the human body! Hence our interest lies in establishing a link between microRNA regulation of gene expression and human diseases, especially those affecting the elderly, such as chronic renal failure and its highly prevailing cardiovascular complications. One element that has not received much consideration is the platelet. This blood element plays a key role in the maintenance of hemostasis as well as in processes underlying myocardial infarction, stroke and complications of chronic kidney disease (CKD). Likely inherited from their megakaryocyte progenitor cells, 15 to 32% of all human genes are present at the mRNA level in platelets! Our preliminary data also indicate that this anucleate blood element may represent the most abundant source of microRNAs humans and modulate mRNA translation via the microRNA pathway. Together, these observations prompted us to hypothesize that the biochemical conditions prevailing in CKD, leading or not to end-stage kidney failure and dialysis, may negatively affect the microRNA pathway of platelets and alter its ability to regulate platelet mRNA translation, thereby favoring the development of serious clinical complications. In addition to offer a new perspective on the deregulation of platelet function in CKD, our study may incriminate microRNAs as an important etiologic factor in thrombotic complications of CKD and provide key insights into novel interventions aimed at monitoring and restoring platelet function in elderly patients.
Program
Catalyst Grant: Pilot Projects in Aging
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
181653
Name
Provost Patrick
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
Study of the microRNA pathway in platelets of elderly dialysis and chronic kidney disease patients
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging
Keyworddelim
Chronic Kidney Disease; Dialysis; Elderly Subjects; Microrna; Platelets; Regulation Of Gene Expression
Abstract
A finely tuned regulatory control of gene expression is required in order to maintain homeostasis and to remain healthy. Recent studies unveiled the existence and biological significance of a gene regulatory mechanism based on tiny RNA species called microRNAs. Generated by the ribonuclease III Dicer, an enzyme that we discovered, microRNAs may regulate up to 90% of the genes, suggesting that every metabolic processes may be under microRNA control in the human body! Hence our interest lies in establishing a link between microRNA regulation of gene expression and human diseases, especially those affecting the elderly, such as chronic renal failure and its highly prevailing cardiovascular complications. One element that has not received much consideration is the platelet. This blood element plays a key role in the maintenance of hemostasis as well as in processes underlying myocardial infarction, stroke and complications of chronic kidney disease (CKD). Likely inherited from their megakaryocyte progenitor cells, 15 to 32% of all human genes are present at the mRNA level in platelets! Our preliminary data also indicate that this anucleate blood element may represent the most abundant source of microRNAs humans and modulate mRNA translation via the microRNA pathway. Together, these observations prompted us to hypothesize that the biochemical conditions prevailing in CKD, leading or not to end-stage kidney failure and dialysis, may negatively affect the microRNA pathway of platelets and alter its ability to regulate platelet mRNA translation, thereby favoring the development of serious clinical complications. In addition to offer a new perspective on the deregulation of platelet function in CKD, our study may incriminate microRNAs as an important etiologic factor in thrombotic complications of CKD and provide key insights into novel interventions aimed at monitoring and restoring platelet function in elderly patients.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Provost, Patrick
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~